Skip to main content
Genertec Universal Medical Group Company Limited logo

Genertec Universal Medical Group Company Limited — Investor Relations & Filings

Ticker · 2666 ISIN · HK0000255361 HKEX Human health and social work activities
Open in API
Filings indexed 784 across all filing types
Latest filing 2026-05-27 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 2666

About Genertec Universal Medical Group Company Limited

http://www.universalmsm.com

Genertec Universal Medical Group Company Limited is a comprehensive healthcare services provider operating across two primary segments: Healthcare Business and Financial Services. The company is committed to the rapidly developing healthcare sector, leveraging its dual focus on service provision and financial support. The Healthcare Business segment encompasses medical and healthcare services, hospital operations, and the import, export, and trading of medical equipment and related goods. The Financial Services segment offers medical equipment leasing, financing, advisory services, hospital construction and management, medical technology, and software development. The company is a listed subsidiary of China General Technology (Group) Holding Co., Ltd, a major State-Owned Enterprise.

Recent filings

Filing Released Lang Actions
COMPLETION OF THE ISSUANCE OF THE FIRST TRANCHE OF DOMESTIC MEDIUM-TERM NOTES IN THE PRC BY GENERTEC UNIVERSAL INTERNATIONAL FINANCIAL LEASING (TIANJIN) CO., LTD., A WHOLLY-OWNED SUBSIDIARY OF THE COM
Capital/Financing Update Classification · 87% confidence The document is a Hong Kong Exchange announcement detailing the completion of a financing transaction – the issuance of RMB0.3 billion of domestic medium-term notes by a wholly-owned subsidiary. It provides terms (maturity, interest rate, issue price) and is made under Listing Rule disclosure requirements. It is not an equity share issue but a debt financing announcement. This falls under Capital/Financing Update (CAP).
2026-05-27 English
ANNOUNCEMENT IN RELATION TO THE PROPOSED ISSUANCE OF THE FIRST TRANCHE OF DOMESTIC MEDIUM-TERM NOTES IN THE PRC BY GENERTEC UNIVERSAL INTERNATIONAL FINANCIAL LEASING (TIANJIN) CO., LTD., A WHOLLY-OWNE
Capital/Financing Update Classification · 92% confidence The document is an announcement by a listed company regarding the proposed issuance of the first tranche of domestic medium-term notes (debt financing) by its subsidiary, detailing principal amount, interest terms, underwriter, use of proceeds, and issuance arrangements. This clearly falls under updates on the company’s fundraising and financing activities rather than a report of financial results or regulatory disclosure of a completed report. Therefore, it is classified as a Capital/Financing Update.
2026-05-25 English
DELAY IN DESPATCH OF CIRCULAR
Regulatory Filings Classification · 95% confidence The document is an announcement from Genertec Universal Medical Group Company Limited regarding a delay in the despatch of a circular related to the revision of the annual cap under a procurement framework agreement. It mentions the circular will include details of the revised annual cap and the notice of the Annual General Meeting. The document is short (2135 characters) and serves as a notification about the delay in sending the circular, not the circular or report itself. This fits the pattern of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not contain financial statements or detailed report content.
2026-05-19 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTHS ENDED 30 APRIL 2026
Regulatory Filings Classification · 95% confidence The document is a monthly return filing (Form FF301) submitted to the Hong Kong Exchanges and Clearing Limited (HKEX) regarding movements in securities for the month ended 30 April 2026. It details movements in issued shares, treasury shares, share options, and public float sufficiency confirmation. The document is regulatory in nature, providing compliance confirmations and share capital movements but does not contain financial statements, earnings data, or management discussion. It is not an annual or interim report, earnings release, or investor presentation. It is a regulatory filing related to share capital and compliance with listing rules. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (9385 characters) and content confirm it is not merely an announcement but a formal regulatory submission.
2026-05-07 English
UNAUDITED OPERATION SUMMARY OF THE GROUP FOR THE FIRST QUARTER OF 2026
Earnings Release Classification · 85% confidence The document is an unaudited operating summary for the first quarter ended 31 March 2026, providing key financial highlights (revenue, profit changes, segment performance) without full audited financial statements. It is an initial announcement of quarterly results under the Listing Rules rather than a comprehensive interim report, fitting the definition of an Earnings Release (code ER). Q1 2026
2026-04-29 English
CONTINUING CONNECTED TRANSACTIONS REVISION OF THE ANNUAL CAP UNDER THE MEDICAL RELATED PRODUCT PROCUREMENT FRAMEWORK AGREEMENT
Regulatory Filings Classification · 85% confidence The document is an announcement filed on the Hong Kong Exchange regarding a revision of the annual cap under a continuing connected transaction framework agreement, including background, terms, pricing policy, and procedures for shareholder approval at the upcoming AGM. It is not an actual financial report (10-K, IR, ER), nor an earnings release, proxy statement, or investor presentation. It is a regulatory announcement about connected transactions under the Listing Rules that does not fit any other specific category, making it a general regulatory filing (RNS).
2026-04-27 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.